---
figid: PMC8395224__ijms-22-08522-g006
figtitle: EphB4 as a Novel Target for the EGFR-Independent Suppressive Effects of
  Osimertinib on Cell Cycle Progression in Non-Small Cell Lung Cancer
organisms:
- Homo sapiens
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC8395224
filename: ijms-22-08522-g006.jpg
figlink: /pmc/articles/PMC8395224/figure/ijms-22-08522-f006/
number: F6
caption: The outline of our hypothesis regarding the signal pathway of the anti-cancer
  effect of osimertinib via EphB4. Osimertinib may be involved in the suppression
  of cell proliferation via the EphB4 and p53-p21-Cyclin D1 pathway independent of
  the EGFR pathway in NSCLC cells.
papertitle: EphB4 as a Novel Target for the EGFR-Independent Suppressive Effects of
  Osimertinib on Cell Cycle Progression in Non-Small Cell Lung Cancer.
reftext: Ren Nanamiya, et al. Int J Mol Sci. 2021 Aug;22(16):8522.
year: '2021'
doi: 10.3390/ijms22168522
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: osimertinib | EphB4 | cell cycle | prognostic factor | predictor of therapeutic
  effect
automl_pathway: 0.9171026
figid_alias: PMC8395224__F6
figtype: Figure
redirect_from: /figures/PMC8395224__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8395224__ijms-22-08522-g006.html
  '@type': Dataset
  description: The outline of our hypothesis regarding the signal pathway of the anti-cancer
    effect of osimertinib via EphB4. Osimertinib may be involved in the suppression
    of cell proliferation via the EphB4 and p53-p21-Cyclin D1 pathway independent
    of the EGFR pathway in NSCLC cells.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EPHB4
  - TP53
  - TP63
  - TP73
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - CCND1
  - p53
  - betaTub60D
  - hth
  - dap
  - CycE
  - cyc
---
